| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.33e-05 | 11 | 106 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | 4-hydroxybutyrate receptor activity | 2.79e-05 | 2 | 106 | 2 | GO:0062124 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.76e-04 | 5 | 106 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | riboflavin transmembrane transporter activity | 4.13e-04 | 6 | 106 | 2 | GO:0032217 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 5.76e-04 | 7 | 106 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 5.76e-04 | 7 | 106 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 6.45e-04 | 32 | 106 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.49e-04 | 130 | 106 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | kinase activity | GALK1 EPHA6 OBSCN AK9 SIK3 CERT1 CDK10 ITK GUCY2F FER MST1L EPHA1 | 7.38e-04 | 764 | 106 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 9.14e-04 | 36 | 106 | 3 | GO:0070273 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.22e-03 | 10 | 106 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | Tat protein binding | 1.22e-03 | 10 | 106 | 2 | GO:0030957 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.22e-03 | 10 | 106 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.22e-03 | 10 | 106 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PIGN GALK1 EPHA6 OBSCN AK9 SIK3 CERT1 CDK10 ITK GUCY2F FER MST1L EPHA1 | 1.39e-03 | 938 | 106 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.44e-03 | 42 | 106 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | transition metal ion binding | TRIT1 LMCD1 ACR CYP4F2 ATP13A2 F8 BHMT MELTF ADAMTS9 JMJD6 TRIM32 TLL2 AFG3L2 GATAD1 CYP4F11 | 1.51e-03 | 1189 | 106 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.10e-03 | 13 | 106 | 2 | GO:0016713 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 3.41e-09 | 5 | 107 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 7.97e-05 | 3 | 107 | 2 | GO:0042361 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 1.59e-04 | 4 | 107 | 2 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 1.59e-04 | 4 | 107 | 2 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 1.59e-04 | 4 | 107 | 2 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 1.59e-04 | 4 | 107 | 2 | GO:0042377 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 1.59e-04 | 4 | 107 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.64e-04 | 156 | 107 | 6 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.64e-04 | 156 | 107 | 6 | GO:0010927 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 2.51e-04 | 239 | 107 | 7 | GO:0031032 | |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 2.54e-04 | 24 | 107 | 3 | GO:0150105 | |
| GeneOntologyBiologicalProcess | flavin-containing compound biosynthetic process | 2.64e-04 | 5 | 107 | 2 | GO:0042727 | |
| GeneOntologyBiologicalProcess | riboflavin metabolic process | 2.64e-04 | 5 | 107 | 2 | GO:0006771 | |
| GeneOntologyBiologicalProcess | flavin adenine dinucleotide biosynthetic process | 2.64e-04 | 5 | 107 | 2 | GO:0072388 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 2.85e-04 | 61 | 107 | 4 | GO:0034332 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 3.63e-04 | 65 | 107 | 4 | GO:0072132 | |
| GeneOntologyBiologicalProcess | flavin-containing compound metabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0042726 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | protein localization to bicellular tight junction | 3.95e-04 | 6 | 107 | 2 | GO:1902396 | |
| GeneOntologyBiologicalProcess | flavin adenine dinucleotide metabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0072387 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 3.95e-04 | 6 | 107 | 2 | GO:1905344 | |
| GeneOntologyBiologicalProcess | riboflavin transport | 3.95e-04 | 6 | 107 | 2 | GO:0032218 | |
| GeneOntologyBiologicalProcess | protein localization to adherens junction | 3.95e-04 | 6 | 107 | 2 | GO:0071896 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 3.95e-04 | 6 | 107 | 2 | GO:0062232 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DSCAM MYO10 ACTB PCDHB12 ACTG1 NCAM1 CD83 TENM4 HMCN2 TJP1 BTN2A3P FER PKHD1 CDH2 CDON | 4.40e-04 | 1077 | 107 | 15 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHA6 DSCAM ACTBL2 ACTB ACTG1 NCAM1 CHRNA3 HMCN2 HECW2 AFG3L2 CDH2 RBFOX2 | 5.02e-04 | 748 | 107 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 5.49e-04 | 31 | 107 | 3 | GO:0098974 | |
| GeneOntologyBiologicalProcess | skeletal muscle thin filament assembly | 5.50e-04 | 7 | 107 | 2 | GO:0030240 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 5.50e-04 | 7 | 107 | 2 | GO:0036102 | |
| GeneOntologyBiologicalProcess | cell recognition | 5.87e-04 | 198 | 107 | 6 | GO:0008037 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 6.49e-04 | 133 | 107 | 5 | GO:0006766 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 7.31e-04 | 8 | 107 | 2 | GO:0036100 | |
| GeneOntologyCellularComponent | myosin filament | 7.84e-06 | 25 | 108 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TJP1 FER NEURL1B MYO18B CDH2 | 8.67e-06 | 576 | 108 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.17e-05 | 32 | 108 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.17e-05 | 32 | 108 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | lamellipodium | 2.60e-05 | 230 | 108 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 8.53e-05 | 45 | 108 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | actin filament | 1.12e-04 | 146 | 108 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 1.58e-04 | 4 | 108 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | filopodium | 4.47e-04 | 123 | 108 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | dense body | 5.46e-04 | 7 | 108 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | myofilament | 5.96e-04 | 32 | 108 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.77e-04 | 290 | 108 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | blood microparticle | 9.13e-04 | 144 | 108 | 5 | GO:0072562 | |
| GeneOntologyCellularComponent | cell body | RBFOX3 DSCAM MYO10 ACTA1 ACTA2 ACTC1 ACTG2 NCAM1 ATP13A2 CHRNA3 HMCN2 ZPBP2 TACR3 | 1.01e-03 | 929 | 108 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | cell leading edge | 1.15e-03 | 500 | 108 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.44e-03 | 94 | 108 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.08e-03 | 104 | 108 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.47e-03 | 109 | 108 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | myofibril | 2.96e-03 | 273 | 108 | 6 | GO:0030016 | |
| Domain | ACTINS_1 | 1.24e-15 | 8 | 106 | 7 | PS00406 | |
| Domain | Actin_CS | 1.70e-12 | 16 | 106 | 7 | IPR004001 | |
| Domain | ACTINS_2 | 2.88e-12 | 17 | 106 | 7 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.69e-12 | 18 | 106 | 7 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 7.39e-12 | 19 | 106 | 7 | PS01132 | |
| Domain | Actin | 3.65e-10 | 31 | 106 | 7 | IPR004000 | |
| Domain | Actin | 3.65e-10 | 31 | 106 | 7 | PF00022 | |
| Domain | ACTIN | 3.65e-10 | 31 | 106 | 7 | SM00268 | |
| Domain | FN3 | EPHA6 DSCAM COL20A1 OBSCN IL20RA NCAM1 LRRN3 OSMR EPHA1 CDON | 1.97e-07 | 199 | 106 | 10 | PS50853 |
| Domain | FN3_dom | EPHA6 DSCAM COL20A1 OBSCN IL20RA NCAM1 LRRN3 OSMR EPHA1 CDON | 3.11e-07 | 209 | 106 | 10 | IPR003961 |
| Domain | fn3 | 3.56e-07 | 162 | 106 | 9 | PF00041 | |
| Domain | Ig-like_fold | EPHA6 DSCAM COL20A1 OBSCN IL20RA NCAM1 CD83 LRRN3 HMCN2 BTN2A3P PKHD1 ZPBP2 IGLL1 OSMR CAMTA1 EPHA1 CDON | 4.56e-07 | 706 | 106 | 17 | IPR013783 |
| Domain | FN3 | 1.09e-06 | 185 | 106 | 9 | SM00060 | |
| Domain | - | EPHA6 DSCAM COL20A1 OBSCN IL20RA NCAM1 CD83 LRRN3 PKHD1 ZPBP2 IGLL1 OSMR CAMTA1 EPHA1 CDON | 4.97e-06 | 663 | 106 | 15 | 2.60.40.10 |
| Domain | Riboflavin_transptr | 9.54e-05 | 3 | 106 | 2 | IPR009357 | |
| Domain | Fox-1_C | 9.54e-05 | 3 | 106 | 2 | PF12414 | |
| Domain | Fox-1_C_dom | 9.54e-05 | 3 | 106 | 2 | IPR025670 | |
| Domain | DUF1011 | 9.54e-05 | 3 | 106 | 2 | PF06237 | |
| Domain | RNA-bd_Fox-1 | 9.54e-05 | 3 | 106 | 2 | IPR017325 | |
| Domain | PROTEIN_KINASE_TYR | 2.28e-04 | 97 | 106 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.28e-04 | 97 | 106 | 5 | IPR008266 | |
| Domain | Ig-like_dom | 5.80e-04 | 503 | 106 | 10 | IPR007110 | |
| Domain | IQ | 7.11e-04 | 71 | 106 | 4 | PF00612 | |
| Domain | Ig_I-set | 7.53e-04 | 190 | 106 | 6 | IPR013098 | |
| Domain | I-set | 7.53e-04 | 190 | 106 | 6 | PF07679 | |
| Domain | - | 7.90e-04 | 73 | 106 | 4 | 2.60.120.260 | |
| Domain | Pkinase_Tyr | 8.44e-04 | 129 | 106 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.14e-03 | 138 | 106 | 5 | IPR001245 | |
| Domain | IQ | 1.17e-03 | 81 | 106 | 4 | SM00015 | |
| Domain | Tyr_kinase_cat_dom | 1.59e-03 | 88 | 106 | 4 | IPR020635 | |
| Domain | TyrKc | 1.59e-03 | 88 | 106 | 4 | SM00219 | |
| Domain | IQ_motif_EF-hand-BS | 1.72e-03 | 90 | 106 | 4 | IPR000048 | |
| Domain | IG_LIKE | 1.92e-03 | 491 | 106 | 9 | PS50835 | |
| Domain | IQ | 1.94e-03 | 93 | 106 | 4 | PS50096 | |
| Domain | Galactose-bd-like | 2.02e-03 | 94 | 106 | 4 | IPR008979 | |
| Domain | IGc2 | 2.23e-03 | 235 | 106 | 6 | SM00408 | |
| Domain | Ig_sub2 | 2.23e-03 | 235 | 106 | 6 | IPR003598 | |
| Domain | NHL | 2.39e-03 | 13 | 106 | 2 | PS51125 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.78e-03 | 14 | 106 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.78e-03 | 14 | 106 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.78e-03 | 14 | 106 | 2 | IPR001426 | |
| Domain | EphA2_TM | 2.78e-03 | 14 | 106 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.78e-03 | 14 | 106 | 2 | IPR001090 | |
| Domain | Eph_TM | 2.78e-03 | 14 | 106 | 2 | IPR027936 | |
| Domain | EPH_lbd | 2.78e-03 | 14 | 106 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 2.78e-03 | 14 | 106 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.78e-03 | 14 | 106 | 2 | IPR016257 | |
| Domain | EPH_LBD | 2.78e-03 | 14 | 106 | 2 | PS51550 | |
| Domain | Glycoside_hydrolase_SF | 3.39e-03 | 53 | 106 | 3 | IPR017853 | |
| Domain | Peptidase_S1A | 3.93e-03 | 113 | 106 | 4 | IPR001314 | |
| Domain | TRYPSIN_DOM | 4.18e-03 | 115 | 106 | 4 | PS50240 | |
| Domain | Tryp_SPc | 4.45e-03 | 117 | 106 | 4 | SM00020 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.60e-03 | 18 | 106 | 2 | PS00754 | |
| Domain | Trypsin_dom | 5.01e-03 | 121 | 106 | 4 | IPR001254 | |
| Domain | Trypsin | 5.01e-03 | 121 | 106 | 4 | PF00089 | |
| Domain | SNF | 5.12e-03 | 19 | 106 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 5.12e-03 | 19 | 106 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.12e-03 | 19 | 106 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.12e-03 | 19 | 106 | 2 | PS50267 | |
| Domain | Peptidase_S1_PA | 5.31e-03 | 123 | 106 | 4 | IPR009003 | |
| Domain | Apc4_WD40_dom | 5.67e-03 | 20 | 106 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 5.67e-03 | 20 | 106 | 2 | PF12894 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 4.07e-07 | 47 | 87 | 6 | M39829 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 8.51e-05 | 38 | 87 | 4 | M39549 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 2.28e-18 | 7 | 108 | 7 | 18443296 | |
| Pubmed | 1.82e-17 | 8 | 108 | 7 | 23260110 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 7.79e-16 | 6 | 108 | 6 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 7.79e-16 | 6 | 108 | 6 | 10074138 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 7.79e-16 | 6 | 108 | 6 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 7.79e-16 | 6 | 108 | 6 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 7.79e-16 | 6 | 108 | 6 | 11709093 | |
| Pubmed | 7.79e-16 | 6 | 108 | 6 | 10049817 | ||
| Pubmed | 7.79e-16 | 6 | 108 | 6 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 7.79e-16 | 6 | 108 | 6 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 7.79e-16 | 6 | 108 | 6 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 7.79e-16 | 6 | 108 | 6 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 7.79e-16 | 6 | 108 | 6 | 8661406 | |
| Pubmed | 7.79e-16 | 6 | 108 | 6 | 23017337 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 7.79e-16 | 6 | 108 | 6 | 23875777 | |
| Pubmed | 7.79e-16 | 6 | 108 | 6 | 9841925 | ||
| Pubmed | 5.44e-15 | 7 | 108 | 6 | 22535526 | ||
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 5.44e-15 | 7 | 108 | 6 | 22640593 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 5.44e-15 | 7 | 108 | 6 | 17504171 | |
| Pubmed | 5.44e-15 | 7 | 108 | 6 | 22465675 | ||
| Pubmed | 2.17e-14 | 8 | 108 | 6 | 14694110 | ||
| Pubmed | 2.17e-14 | 8 | 108 | 6 | 20147394 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 6.49e-14 | 9 | 108 | 6 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 6.49e-14 | 9 | 108 | 6 | 8892894 | |
| Pubmed | 6.49e-14 | 9 | 108 | 6 | 18775311 | ||
| Pubmed | 1.62e-13 | 10 | 108 | 6 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 1.62e-13 | 10 | 108 | 6 | 1991513 | |
| Pubmed | 1.62e-13 | 10 | 108 | 6 | 23575248 | ||
| Pubmed | 3.55e-13 | 11 | 108 | 6 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 3.55e-13 | 11 | 108 | 6 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 3.55e-13 | 11 | 108 | 6 | 19639585 | |
| Pubmed | 7.09e-13 | 12 | 108 | 6 | 23071112 | ||
| Pubmed | 2.29e-12 | 14 | 108 | 6 | 21923909 | ||
| Pubmed | 2.29e-12 | 14 | 108 | 6 | 17411366 | ||
| Pubmed | 9.38e-12 | 17 | 108 | 6 | 17360745 | ||
| Pubmed | 9.38e-12 | 17 | 108 | 6 | 8997639 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 5.58e-11 | 22 | 108 | 6 | 16526095 | |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 7.53e-11 | 23 | 108 | 6 | 22004035 | |
| Pubmed | 1.71e-10 | 26 | 108 | 6 | 24742657 | ||
| Pubmed | 2.18e-09 | 18 | 108 | 5 | 24840128 | ||
| Pubmed | 6.10e-09 | 8 | 108 | 4 | 20096780 | ||
| Pubmed | Drebrin, an actin-binding protein, is required for lens morphogenesis and growth. | 1.82e-08 | 10 | 108 | 4 | 33896079 | |
| Pubmed | Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. | 2.91e-08 | 3 | 108 | 3 | 1728592 | |
| Pubmed | Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. | 2.91e-08 | 3 | 108 | 3 | 22403730 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 3842206 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 6641707 | ||
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 2.91e-08 | 3 | 108 | 3 | 7780165 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 6865942 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 3084797 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 11812134 | ||
| Pubmed | The formin-homology-domain-containing protein FHOD1 enhances cell migration. | 1.16e-07 | 4 | 108 | 3 | 12665555 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 2201580 | ||
| Pubmed | The proline-rich domain of tau plays a role in interactions with actin. | 1.16e-07 | 4 | 108 | 3 | 19895707 | |
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 1.17e-07 | 15 | 108 | 4 | 30562487 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.17e-07 | 15 | 108 | 4 | 16824795 | |
| Pubmed | 2.30e-07 | 43 | 108 | 5 | 20876399 | ||
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 2.30e-07 | 43 | 108 | 5 | 18804439 | |
| Pubmed | Microtubule associated protein MAP1A is an actin-binding and crosslinking protein. | 2.90e-07 | 5 | 108 | 3 | 7820861 | |
| Pubmed | D186/D190 is an allele-dependent determinant of HIV-1 Nef function. | 2.90e-07 | 5 | 108 | 3 | 27560372 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 22855531 | ||
| Pubmed | 5.76e-07 | 96 | 108 | 6 | 23580065 | ||
| Pubmed | Nef interaction with actin compromises human podocyte actin cytoskeletal integrity. | 7.44e-07 | 23 | 108 | 4 | 22721673 | |
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.01e-06 | 7 | 108 | 3 | 9384381 | |
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 30289203 | ||
| Pubmed | 1.10e-06 | 247 | 108 | 8 | 30713523 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 1.25e-06 | 26 | 108 | 4 | 34848499 | |
| Pubmed | Cellular and molecular properties of neural progenitors in the developing mammalian hypothalamus. | 1.61e-06 | 8 | 108 | 3 | 32792525 | |
| Pubmed | RBFOX2 is required for establishing RNA regulatory networks essential for heart development. | 1.61e-06 | 8 | 108 | 3 | 35137168 | |
| Pubmed | AP-2α is required after lens vesicle formation to maintain lens integrity. | 1.61e-06 | 8 | 108 | 3 | 24753151 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 2983233 | ||
| Pubmed | HAND2-mediated epithelial maintenance and integrity in cardiac outflow tract morphogenesis. | 1.97e-06 | 29 | 108 | 4 | 31201155 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.20e-06 | 271 | 108 | 8 | 32433965 | |
| Pubmed | The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion. | 2.41e-06 | 9 | 108 | 3 | 17360635 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 29920846 | ||
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 19710135 | ||
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 2.41e-06 | 9 | 108 | 3 | 12297046 | |
| Pubmed | 2.59e-06 | 31 | 108 | 4 | 22282597 | ||
| Pubmed | 2.96e-06 | 32 | 108 | 4 | 23369715 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 21203488 | ||
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 3.44e-06 | 10 | 108 | 3 | 21749862 | |
| Pubmed | Proteomic analysis reveals novel binding partners of MIP-T3 in human cells. | 3.80e-06 | 34 | 108 | 4 | 20391533 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 22207710 | ||
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 17556662 | ||
| Pubmed | 4.76e-06 | 513 | 108 | 10 | 25798074 | ||
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 6.28e-06 | 12 | 108 | 3 | 31042497 | |
| Pubmed | A cell polarity protein aPKClambda is required for eye lens formation and growth. | 6.28e-06 | 12 | 108 | 3 | 19835853 | |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 22491404 | ||
| Pubmed | 7.37e-06 | 40 | 108 | 4 | 26657772 | ||
| Pubmed | 8.14e-06 | 13 | 108 | 3 | 17553984 | ||
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 8.14e-06 | 13 | 108 | 3 | 18400219 | |
| Pubmed | EPHA6 DSCAM MYO10 ABHD2 PRSS55 HPSE2 CD83 CHRNA3 TENM4 SLC6A5 OSMR CDH2 | 8.92e-06 | 814 | 108 | 12 | 23251661 | |
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 8.99e-06 | 42 | 108 | 4 | 14760703 | |
| Pubmed | The identification of myocilin-associated proteins in the human trabecular meshwork. | 8.99e-06 | 42 | 108 | 4 | 16289162 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 9.55e-06 | 2 | 108 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 9.55e-06 | 2 | 108 | 2 | 22366783 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 9.55e-06 | 2 | 108 | 2 | 32588558 | |
| Pubmed | Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation. | 9.55e-06 | 2 | 108 | 2 | 38127465 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20706863 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27625340 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15721306 | ||
| Interaction | ACTG2 interactions | 3.16e-12 | 49 | 104 | 9 | int:ACTG2 | |
| Interaction | POTEJ interactions | 2.39e-10 | 52 | 104 | 8 | int:POTEJ | |
| Interaction | CAP2 interactions | 1.72e-09 | 66 | 104 | 8 | int:CAP2 | |
| Interaction | DNASE1 interactions | 2.31e-08 | 7 | 104 | 4 | int:DNASE1 | |
| Interaction | POTEI interactions | 7.06e-08 | 105 | 104 | 8 | int:POTEI | |
| Interaction | PFN3 interactions | 1.37e-07 | 10 | 104 | 4 | int:PFN3 | |
| Interaction | WASH8P interactions | 2.15e-07 | 11 | 104 | 4 | int:WASH8P | |
| Interaction | PHACTR2 interactions | 3.57e-07 | 29 | 104 | 5 | int:PHACTR2 | |
| Interaction | POTEE interactions | 4.67e-07 | 134 | 104 | 8 | int:POTEE | |
| Interaction | ACTA1 interactions | MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TRIM32 TJP1 MEPCE CDH2 | 4.79e-07 | 371 | 104 | 12 | int:ACTA1 |
| Interaction | SCIN interactions | 5.32e-07 | 58 | 104 | 6 | int:SCIN | |
| Interaction | FBXO40 interactions | 8.74e-07 | 15 | 104 | 4 | int:FBXO40 | |
| Interaction | NAA80 interactions | 8.74e-07 | 15 | 104 | 4 | int:NAA80 | |
| Interaction | ABRA interactions | 1.10e-06 | 36 | 104 | 5 | int:ABRA | |
| Interaction | ERRFI1 interactions | 1.36e-06 | 107 | 104 | 7 | int:ERRFI1 | |
| Interaction | REG3A interactions | 1.51e-06 | 17 | 104 | 4 | int:REG3A | |
| Interaction | ACTA2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 CDK10 UBE2H GUCY2F MEPCE | 2.25e-06 | 355 | 104 | 11 | int:ACTA2 |
| Interaction | LRRC20 interactions | 2.44e-06 | 19 | 104 | 4 | int:LRRC20 | |
| Interaction | ACTBL2 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 CDK10 YEATS4 MEPCE | 3.10e-06 | 296 | 104 | 10 | int:ACTBL2 |
| Interaction | TMSB4X interactions | 3.60e-06 | 80 | 104 | 6 | int:TMSB4X | |
| Interaction | PDCL3 interactions | 1.31e-05 | 100 | 104 | 6 | int:PDCL3 | |
| Interaction | PLEC interactions | DSCAM ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 EEF1D TJP1 MYO18B | 1.38e-05 | 430 | 104 | 11 | int:PLEC |
| Interaction | ANGPTL8 interactions | 1.56e-05 | 10 | 104 | 3 | int:ANGPTL8 | |
| Interaction | C6orf47 interactions | 1.65e-05 | 30 | 104 | 4 | int:C6orf47 | |
| Interaction | GC interactions | 1.70e-05 | 62 | 104 | 5 | int:GC | |
| Interaction | MRGBP interactions | 2.15e-05 | 109 | 104 | 6 | int:MRGBP | |
| Interaction | POTEF interactions | 2.41e-05 | 228 | 104 | 8 | int:POTEF | |
| Interaction | SCGB1A1 interactions | 2.84e-05 | 12 | 104 | 3 | int:SCGB1A1 | |
| Interaction | CFL1 interactions | 2.98e-05 | 384 | 104 | 10 | int:CFL1 | |
| Interaction | PPP1R1A interactions | 3.68e-05 | 13 | 104 | 3 | int:PPP1R1A | |
| Interaction | PCYT1B interactions | 3.68e-05 | 13 | 104 | 3 | int:PCYT1B | |
| Interaction | YEATS4 interactions | 4.44e-05 | 182 | 104 | 7 | int:YEATS4 | |
| Interaction | RNASE3 interactions | 4.66e-05 | 14 | 104 | 3 | int:RNASE3 | |
| Interaction | SRCAP interactions | 5.10e-05 | 127 | 104 | 6 | int:SRCAP | |
| Interaction | CALD1 interactions | 6.97e-05 | 265 | 104 | 8 | int:CALD1 | |
| Interaction | WIPF3 interactions | 7.12e-05 | 16 | 104 | 3 | int:WIPF3 | |
| Interaction | LIMA1 interactions | 7.56e-05 | 429 | 104 | 10 | int:LIMA1 | |
| Interaction | EFHB interactions | 7.89e-05 | 3 | 104 | 2 | int:EFHB | |
| Interaction | ERBB3 interactions | 9.32e-05 | 355 | 104 | 9 | int:ERBB3 | |
| Interaction | CAP1 interactions | 9.97e-05 | 207 | 104 | 7 | int:CAP1 | |
| Interaction | NEXN interactions | 1.09e-04 | 91 | 104 | 5 | int:NEXN | |
| Interaction | MYOC interactions | 1.09e-04 | 48 | 104 | 4 | int:MYOC | |
| Interaction | GSN interactions | 1.16e-04 | 212 | 104 | 7 | int:GSN | |
| Interaction | DST interactions | 1.21e-04 | 287 | 104 | 8 | int:DST | |
| Interaction | WASHC1 interactions | 1.27e-04 | 94 | 104 | 5 | int:WASHC1 | |
| Interaction | TMCC2 interactions | 1.28e-04 | 50 | 104 | 4 | int:TMCC2 | |
| Interaction | DUSP19 interactions | 1.40e-04 | 96 | 104 | 5 | int:DUSP19 | |
| Interaction | LIAT1 interactions | 1.57e-04 | 4 | 104 | 2 | int:LIAT1 | |
| Interaction | TWF2 interactions | 1.70e-04 | 100 | 104 | 5 | int:TWF2 | |
| Interaction | CDK10 interactions | 1.74e-04 | 54 | 104 | 4 | int:CDK10 | |
| Interaction | PFN2 interactions | 1.76e-04 | 159 | 104 | 6 | int:PFN2 | |
| Interaction | FBXO30 interactions | 2.00e-04 | 56 | 104 | 4 | int:FBXO30 | |
| Interaction | TMSB10 interactions | 2.00e-04 | 56 | 104 | 4 | int:TMSB10 | |
| Interaction | ADARB1 interactions | ACTBL2 TAF1A ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 EEF1D RBFOX2 | 2.20e-04 | 489 | 104 | 10 | int:ADARB1 |
| Interaction | NPHP4 interactions | 2.24e-04 | 236 | 104 | 7 | int:NPHP4 | |
| Interaction | COTL1 interactions | 2.29e-04 | 58 | 104 | 4 | int:COTL1 | |
| Interaction | PNPLA8 interactions | 2.29e-04 | 58 | 104 | 4 | int:PNPLA8 | |
| Interaction | MORF4L2 interactions | 2.37e-04 | 168 | 104 | 6 | int:MORF4L2 | |
| Interaction | OR7A17 interactions | 2.61e-04 | 5 | 104 | 2 | int:OR7A17 | |
| Interaction | ACTR10 interactions | 2.65e-04 | 110 | 104 | 5 | int:ACTR10 | |
| Interaction | MACF1 interactions | 2.95e-04 | 247 | 104 | 7 | int:MACF1 | |
| Interaction | BCL7C interactions | 3.25e-04 | 115 | 104 | 5 | int:BCL7C | |
| Interaction | CCT4 interactions | 3.32e-04 | 515 | 104 | 10 | int:CCT4 | |
| Interaction | WASL interactions | 3.52e-04 | 117 | 104 | 5 | int:WASL | |
| Interaction | SPIRE1 interactions | 3.57e-04 | 27 | 104 | 3 | int:SPIRE1 | |
| Interaction | CCT5 interactions | 3.86e-04 | 525 | 104 | 10 | int:CCT5 | |
| Interaction | EP400 interactions | 3.86e-04 | 184 | 104 | 6 | int:EP400 | |
| Interaction | ARHGAP12 interactions | 4.23e-04 | 68 | 104 | 4 | int:ARHGAP12 | |
| Interaction | ACTB interactions | MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TBL1XR1 CDK10 YEATS4 UBE2H TJP1 MEPCE MYO18B | 4.36e-04 | 1083 | 104 | 15 | int:ACTB |
| Interaction | NPB interactions | 4.42e-04 | 29 | 104 | 3 | int:NPB | |
| Interaction | DMAP1 interactions | 4.71e-04 | 191 | 104 | 6 | int:DMAP1 | |
| Interaction | PLS1 interactions | 4.95e-04 | 126 | 104 | 5 | int:PLS1 | |
| Interaction | ENAH interactions | 4.95e-04 | 126 | 104 | 5 | int:ENAH | |
| Interaction | DUSP10 interactions | 4.99e-04 | 71 | 104 | 4 | int:DUSP10 | |
| Interaction | MOB1A interactions | 5.26e-04 | 72 | 104 | 4 | int:MOB1A | |
| Interaction | GUCY2F interactions | 5.45e-04 | 7 | 104 | 2 | int:GUCY2F | |
| Interaction | BAIAP2L1 interactions | 5.51e-04 | 129 | 104 | 5 | int:BAIAP2L1 | |
| Cytoband | 10q23-q24 | 1.95e-04 | 9 | 108 | 2 | 10q23-q24 | |
| GeneFamily | Actins | 5.73e-15 | 6 | 79 | 6 | 929 | |
| GeneFamily | Fibronectin type III domain containing | 3.22e-08 | 160 | 79 | 9 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.38e-05 | 161 | 79 | 6 | 593 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.66e-03 | 14 | 79 | 2 | 1095 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 8.97e-06 | 32 | 108 | 4 | MM657 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 1.02e-05 | 33 | 108 | 4 | M7409 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 1.91e-05 | 199 | 108 | 7 | M8415 | |
| Coexpression | ATM_DN.V1_DN | 3.23e-05 | 146 | 108 | 6 | M2691 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_200 | 1.41e-06 | 160 | 106 | 8 | gudmap_developingLowerUrinaryTract_adult_bladder_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_200 | 1.42e-06 | 39 | 106 | 5 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_100 | 2.78e-06 | 79 | 106 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | PIGN RBFOX3 LMCD1 NAB1 ACTA2 ACTB ACTC1 ACTG2 INTS8 NEURL1B RBFOX2 | 4.38e-06 | 393 | 106 | 11 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200 | 5.00e-06 | 50 | 106 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 8.06e-06 | 26 | 106 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_200 | 9.08e-06 | 147 | 106 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 1.10e-05 | 28 | 106 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_500 | 1.61e-05 | 107 | 106 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k4 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.64e-05 | 293 | 106 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_200 | 1.64e-05 | 161 | 106 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_200_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 1.85e-05 | 164 | 106 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 2.43e-05 | 115 | 106 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 2.46e-05 | 69 | 106 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | PIGN EHBP1 RBFOX3 LMCD1 NAB1 ACTA2 ACTB ACTC1 ACTG2 NCAM1 INTS8 C2CD3 NEURL1B RBFOX2 | 2.99e-05 | 772 | 106 | 14 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | PIGN MYO10 NAB1 ACTA2 ACTG2 NCAM1 GLB1L2 TBL1XR1 CERT1 INTS8 KCNG1 NEURL1B CDH2 RBFOX2 | 5.11e-05 | 811 | 106 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100 | 5.27e-05 | 15 | 106 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_500 | 7.12e-05 | 86 | 106 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 7.12e-05 | 86 | 106 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_200 | 7.81e-05 | 17 | 106 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 7.95e-05 | 88 | 106 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500 | 9.64e-05 | 48 | 106 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100 | 1.11e-04 | 19 | 106 | 3 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 1.17e-04 | 378 | 106 | 9 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_200 | 1.53e-04 | 160 | 106 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_200_B | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 1.75e-04 | 164 | 106 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 2.62e-04 | 421 | 106 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500 | 2.91e-04 | 116 | 106 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_200 | 3.24e-04 | 27 | 106 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_200_k4 | |
| CoexpressionAtlas | parathyroid gland | 3.52e-04 | 347 | 106 | 8 | parathyroid gland | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_500 | 3.54e-04 | 187 | 106 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k5 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_200 | 3.74e-04 | 68 | 106 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_100 | 4.02e-04 | 29 | 106 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.08e-04 | 192 | 106 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_200 | 4.31e-04 | 194 | 106 | 6 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_200 | 4.91e-04 | 31 | 106 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_100 | 5.40e-04 | 32 | 106 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 5.48e-04 | 371 | 106 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | SLC6A17 NAB1 ACTA1 ACTA2 ACTC1 ACTG2 HPSE2 GLB1L2 PI15 ADAMTS9 PKHD1 OSMR NEURL1B | 5.73e-04 | 905 | 106 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 6.00e-04 | 77 | 106 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 6.87e-04 | 384 | 106 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_100 | 6.93e-04 | 80 | 106 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_200 | 7.05e-04 | 35 | 106 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 7.35e-04 | 388 | 106 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500 | 7.60e-04 | 390 | 106 | 8 | gudmap_developingLowerUrinaryTract_P1_ureter_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_100 | 7.96e-04 | 83 | 106 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_100_B | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.30e-04 | 37 | 106 | 3 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.52e-04 | 397 | 106 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | ACTA2 PCDHB12 ACTC1 ACTG2 NCAM1 GLB1L2 TBL1XR1 CERT1 HECW2 NEURL1B CDH2 RBFOX2 | 8.54e-04 | 826 | 106 | 12 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_100 | 8.69e-04 | 9 | 106 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.86e-04 | 307 | 106 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 9.50e-04 | 87 | 106 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_200 | 9.92e-04 | 88 | 106 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.98e-04 | 152 | 106 | 5 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-09 | 197 | 108 | 9 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.53e-08 | 182 | 108 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-08 | 191 | 108 | 8 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-08 | 191 | 108 | 8 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.95e-08 | 198 | 108 | 8 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-08 | 145 | 108 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-07 | 171 | 108 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-07 | 173 | 108 | 7 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-07 | 173 | 108 | 7 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.49e-07 | 176 | 108 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.79e-07 | 179 | 108 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 180 | 108 | 7 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 180 | 108 | 7 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.88e-07 | 188 | 108 | 7 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-07 | 190 | 108 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-07 | 190 | 108 | 7 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.32e-07 | 191 | 108 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.32e-07 | 191 | 108 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.48e-07 | 192 | 108 | 7 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.48e-07 | 192 | 108 | 7 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.64e-07 | 193 | 108 | 7 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.64e-07 | 193 | 108 | 7 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-07 | 197 | 108 | 7 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-07 | 197 | 108 | 7 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.32e-07 | 197 | 108 | 7 | 1a6b2ca94a4634c24cd95481576c955b20000a5f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.32e-07 | 197 | 108 | 7 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.51e-07 | 198 | 108 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.89e-07 | 200 | 108 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.89e-07 | 200 | 108 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | fc2fc3bfcf1ad9bfb9fe07bbed8068126930bee6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.44e-07 | 129 | 108 | 6 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-06 | 159 | 108 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-06 | 162 | 108 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-06 | 166 | 108 | 6 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-06 | 166 | 108 | 6 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 167 | 108 | 6 | 4ae9f2c5df13463709ea880ab035965fd99e7626 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 167 | 108 | 6 | 4e58f9bf1e9d47720c871776ec34513ded4de9b7 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.71e-06 | 170 | 108 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.83e-06 | 171 | 108 | 6 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.83e-06 | 171 | 108 | 6 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.10e-06 | 173 | 108 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.38e-06 | 175 | 108 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.99e-06 | 179 | 108 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | COPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class | 4.99e-06 | 179 | 108 | 6 | 5c705627bd13a5b2c7b0062fb3d94e4eb1589327 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.15e-06 | 180 | 108 | 6 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.31e-06 | 181 | 108 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.31e-06 | 181 | 108 | 6 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.31e-06 | 181 | 108 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.31e-06 | 181 | 108 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.84e-06 | 184 | 108 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.84e-06 | 184 | 108 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.02e-06 | 185 | 108 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.02e-06 | 185 | 108 | 6 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.40e-06 | 187 | 108 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.40e-06 | 187 | 108 | 6 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 188 | 108 | 6 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 188 | 108 | 6 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.60e-06 | 188 | 108 | 6 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | normal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass | 6.60e-06 | 188 | 108 | 6 | fd70fb89570f014d1299c60fe017dc09f24e57c6 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 188 | 108 | 6 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.60e-06 | 188 | 108 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-06 | 188 | 108 | 6 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.60e-06 | 188 | 108 | 6 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.81e-06 | 189 | 108 | 6 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.01e-06 | 190 | 108 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Tregs|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.01e-06 | 190 | 108 | 6 | f69a4733b5d1542ab4d0eb44856f2c5c34c18b9e | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.01e-06 | 190 | 108 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-06 | 190 | 108 | 6 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-06 | 190 | 108 | 6 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-06 | 190 | 108 | 6 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-06 | 190 | 108 | 6 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.23e-06 | 191 | 108 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 192 | 108 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | Fibroblast-D_(Pericyte)|World / shred on cell class and cell subclass (v4) | 7.45e-06 | 192 | 108 | 6 | 8c13c351fcc3d88e8c2ffa017e71ff6272cc6fac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-06 | 192 | 108 | 6 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.67e-06 | 193 | 108 | 6 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.67e-06 | 193 | 108 | 6 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.67e-06 | 193 | 108 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like-IPCs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.67e-06 | 193 | 108 | 6 | 2088f1d210c73f74685492c63065c62ac3f553e9 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.67e-06 | 193 | 108 | 6 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.67e-06 | 193 | 108 | 6 | f24bae40f5cbcfece04fbefe4e3de1b88ac90de4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.67e-06 | 193 | 108 | 6 | b1893193766ae41bf2ab6ed4083285c9c814e608 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.67e-06 | 193 | 108 | 6 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-06 | 194 | 108 | 6 | 91205b22650e7ecdb72bb59348ce2530b76c532c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.90e-06 | 194 | 108 | 6 | 6a4e7f1bf67bad94cd8c472e7c66798b0c25ba01 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-06 | 194 | 108 | 6 | 6e12a7da35be4c0ecf998ef94b8989b89d74b200 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-06 | 194 | 108 | 6 | bea369e9a7018d862e4d7f1c9ec2de50f3fd38ec | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-06 | 194 | 108 | 6 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-06 | 194 | 108 | 6 | c52f10140c66e8c0566421c3d535d5d92bf595e1 | |
| Computational | Muscle genes. | 9.26e-05 | 37 | 70 | 4 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 2.80e-04 | 49 | 70 | 4 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 3.27e-04 | 51 | 70 | 4 | MODULE_329 | |
| Drug | azaspiracid | 1.06e-12 | 30 | 108 | 8 | CID006451158 | |
| Drug | Nsc687160 | 1.35e-12 | 18 | 108 | 7 | CID005459290 | |
| Drug | AC1L1HS4 | 1.88e-12 | 32 | 108 | 8 | CID000004267 | |
| Drug | tolytoxin | 2.13e-12 | 19 | 108 | 7 | CID006440827 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 3.23e-12 | 34 | 108 | 8 | CID000001312 | |
| Drug | NSC312786 | 4.88e-12 | 21 | 108 | 7 | CID000329495 | |
| Drug | AC1L8NVR | 4.88e-12 | 21 | 108 | 7 | CID000384633 | |
| Drug | AC1NSKFN | 5.34e-12 | 36 | 108 | 8 | CID005311324 | |
| Drug | fluorescein isothiocyanate | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 NCAM1 CD83 TJP1 GATAD1 LY75 | 5.46e-12 | 147 | 108 | 12 | CID000018730 |
| Drug | epsilon-ATP | 1.65e-11 | 41 | 108 | 8 | CID000162262 | |
| Drug | AC1Q6LQU | 6.35e-11 | 48 | 108 | 8 | CID000072380 | |
| Drug | blebbistatin | MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MYO18B EPHA1 | 2.02e-10 | 116 | 108 | 10 | CID003476986 |
| Drug | N,N'-p-phenylenedimaleimide | 2.15e-10 | 34 | 108 | 7 | CID000076765 | |
| Drug | m2-19 | 2.55e-10 | 19 | 108 | 6 | CID000079129 | |
| Drug | Mgamp-pnp | 5.07e-10 | 21 | 108 | 6 | CID005311323 | |
| Drug | caged ATP | 1.46e-09 | 70 | 108 | 8 | CID000123806 | |
| Drug | AC1L8FNU | 1.47e-09 | 44 | 108 | 7 | CID000425429 | |
| Drug | beryllium fluoride | 1.50e-09 | 103 | 108 | 9 | CID000024589 | |
| Drug | 6-trans-leukotriene B4 | ACTBL2 NAB1 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HPSE2 CYP4F2 CYP4F11 PLD4 | 2.26e-09 | 247 | 108 | 12 | CID000000169 |
| Drug | NpCaM | 2.78e-09 | 48 | 108 | 7 | CID000122259 | |
| Drug | CID5288653 | 3.43e-09 | 28 | 108 | 6 | CID005288653 | |
| Drug | AC1L9EF8 | 3.89e-09 | 79 | 108 | 8 | CID000443315 | |
| Drug | B0683 | 4.68e-09 | 117 | 108 | 9 | CID006398969 | |
| Drug | plakin | 5.25e-09 | 82 | 108 | 8 | CID000018752 | |
| Drug | 3-methylhistidine | 7.47e-09 | 55 | 108 | 7 | CID000064969 | |
| Drug | dihydrocytochalasin B | 1.09e-08 | 58 | 108 | 7 | CID000003064 | |
| Drug | AC1L1GXW | 1.56e-08 | 94 | 108 | 8 | CID000003891 | |
| Drug | Aspidium | 1.82e-08 | 184 | 108 | 10 | CID000000815 | |
| Drug | AC1NRBPQ | 1.87e-08 | 137 | 108 | 9 | CID005288569 | |
| Drug | oryzalin | 1.97e-08 | 63 | 108 | 7 | CID000029393 | |
| Drug | quinacrine | ACR ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ITK IGLL1 PLD4 | 2.27e-08 | 243 | 108 | 11 | CID000000237 |
| Drug | DE gel | 2.72e-08 | 143 | 108 | 9 | CID000008146 | |
| Drug | 5-IAF | 2.75e-08 | 66 | 108 | 7 | CID000123822 | |
| Drug | NSC 523214 | 3.46e-08 | 147 | 108 | 9 | CID000004752 | |
| Drug | chlorpromazine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TRIM32 CYP4F11 PLD4 | 3.47e-08 | 197 | 108 | 10 | CID000002726 |
| Drug | AC1L1ERT | 3.76e-08 | 69 | 108 | 7 | CID000002920 | |
| Drug | (2S,3R)-Sphingosine | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACY1 CHRNA3 SLC20A1 GATAD1 IGLL1 PLD4 | 4.12e-08 | 389 | 108 | 13 | CID000001104 |
| Drug | trifluoperazine | MGAM MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 CHRNA3 TRIM32 MYO18B | 4.63e-08 | 324 | 108 | 12 | CID000005566 |
| Drug | CaCl2 | 5.79e-08 | 156 | 108 | 9 | CID000024854 | |
| Drug | C3H2N2O3S | 6.15e-08 | 74 | 108 | 7 | CID000448652 | |
| Drug | TCNB | 1.00e-07 | 119 | 108 | 8 | CID000008330 | |
| Drug | auxin | TRIT1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HPSE2 TMEM131 | 1.16e-07 | 224 | 108 | 10 | CID000000801 |
| Drug | NSC106399 | 1.50e-07 | 51 | 108 | 6 | CID000002887 | |
| Drug | bistheonellide A | 1.54e-07 | 11 | 108 | 4 | CID006441172 | |
| Drug | Viroisin | 1.54e-07 | 11 | 108 | 4 | CID000119538 | |
| Drug | formamide | 1.62e-07 | 85 | 108 | 7 | CID000000713 | |
| Drug | 2C5P | 1.66e-07 | 127 | 108 | 8 | CID000447961 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 1.75e-07 | 86 | 108 | 7 | CID000000805 | |
| Drug | NSC613009 | 1.98e-07 | 130 | 108 | 8 | CID000003800 | |
| Drug | Formyl | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HPSE2 ALDH1L1 PLD4 | 2.04e-07 | 238 | 108 | 10 | CID000123370 |
| Drug | BFDGE | 2.30e-07 | 12 | 108 | 4 | CID000091511 | |
| Drug | NSC107658 | MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HPSE2 MYO18B PLD4 | 2.34e-07 | 306 | 108 | 11 | CID000002919 |
| Drug | AC1NRCMD | 2.40e-07 | 90 | 108 | 7 | CID005289074 | |
| Drug | AC1L22RD | 2.59e-07 | 91 | 108 | 7 | CID000065183 | |
| Drug | C18:1n-7 | 2.79e-07 | 92 | 108 | 7 | CID000122325 | |
| Drug | mDia | 3.01e-07 | 93 | 108 | 7 | CID000128346 | |
| Drug | NSC339663 | 3.21e-07 | 250 | 108 | 10 | CID000003892 | |
| Drug | manidipine | 3.48e-07 | 95 | 108 | 7 | CID000004008 | |
| Drug | serotonin | MGAM ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 CHRNA3 JMJD6 TRIM32 SLC6A5 TACR3 PLD4 | 3.72e-07 | 554 | 108 | 14 | CID000005202 |
| Drug | NSC3096 | 4.31e-07 | 98 | 108 | 7 | CID000002832 | |
| Drug | kabiramide C | 4.62e-07 | 14 | 108 | 4 | CID005288658 | |
| Drug | dihydrosphingosine | 4.83e-07 | 146 | 108 | 8 | CID000003126 | |
| Drug | K-Cl | MGAM MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 INTS8 GUCY2F TACR3 MYO18B PLD4 | 4.91e-07 | 567 | 108 | 14 | CID000004873 |
| Drug | sulphoxide | 5.29e-07 | 101 | 108 | 7 | CID000008442 | |
| Drug | AC1OAGGW | 5.45e-07 | 203 | 108 | 9 | CID006857364 | |
| Drug | arabinosyladenine | MGAM TRIT1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MLLT10 F8 YEATS4 GUCY2F IGLL1 RBFOX2 PLD4 | 6.12e-07 | 762 | 108 | 16 | CID000000191 |
| Drug | nitroglycerin | 6.16e-07 | 206 | 108 | 9 | CID000004510 | |
| Drug | carbodiimide | 6.25e-07 | 151 | 108 | 8 | CID000009864 | |
| Drug | isoproterenol | TRIT1 MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HPSE2 CHRNA3 GUCY2F SLC52A2 MYO18B PLD4 | 6.28e-07 | 669 | 108 | 15 | CID000003779 |
| Drug | bumetanide | 6.95e-07 | 209 | 108 | 9 | CID000002471 | |
| Drug | phenylarsine oxide | 7.68e-07 | 275 | 108 | 10 | CID000004778 | |
| Drug | AC1LCVPZ | 9.46e-07 | 110 | 108 | 7 | CID000656926 | |
| Drug | MgCl2 | MGAM MYO10 ACR ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 MYO18B | 9.88e-07 | 354 | 108 | 11 | CID000024584 |
| Drug | AC1MNW2N | 1.01e-06 | 70 | 108 | 6 | CID003359490 | |
| Drug | HU-211 | 1.20e-06 | 114 | 108 | 7 | CID000107778 | |
| Drug | L-Carnosine | 1.30e-06 | 73 | 108 | 6 | CID000009369 | |
| Drug | 1tjp | 1.35e-06 | 116 | 108 | 7 | CID005459371 | |
| Drug | SF6847 | 1.43e-06 | 41 | 108 | 5 | CID000005614 | |
| Drug | eye gene | MYO10 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 GUCY2F MYO18B PLD4 | 1.48e-06 | 369 | 108 | 11 | CID000004782 |
| Drug | Pb m | 1.52e-06 | 118 | 108 | 7 | CID006327255 | |
| Drug | AC1LD8HW | 1.53e-06 | 75 | 108 | 6 | CID000644061 | |
| Drug | AC1L1BDQ | 1.74e-06 | 173 | 108 | 8 | CID000001394 | |
| Drug | 5'IATR | 1.76e-06 | 19 | 108 | 4 | CID000074997 | |
| Drug | SIRIUS | 1.79e-06 | 77 | 108 | 6 | CID000091750 | |
| Drug | AC1L1IZ2 | 1.90e-06 | 304 | 108 | 10 | CID000004795 | |
| Drug | microcystin-LR | 2.76e-06 | 129 | 108 | 7 | CID000445433 | |
| Drug | tetramethylrhodamine isothiocyanate | 2.86e-06 | 47 | 108 | 5 | CID004123009 | |
| Drug | AC1LADJ6 | 2.91e-06 | 130 | 108 | 7 | CID000486032 | |
| Drug | pyrene | 3.06e-06 | 131 | 108 | 7 | CID000031423 | |
| Drug | pseudococaine | TRIT1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ACY1 INTS8 CHRNA3 TRIM32 SLC6A5 | 3.10e-06 | 570 | 108 | 13 | CID000002826 |
| Drug | foscarnet | 3.51e-06 | 190 | 108 | 8 | CID000003414 | |
| Drug | AC1Q3ZOL | 3.95e-06 | 258 | 108 | 9 | CID000002376 | |
| Drug | Rp-cAMPS | 4.09e-06 | 194 | 108 | 8 | CID006426631 | |
| Drug | Nbd-Ph | 4.73e-06 | 24 | 108 | 4 | CID004682184 | |
| Drug | AC1Q5THZ | MGAM ACR ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 HPSE2 GUCY2F PLD4 | 4.75e-06 | 502 | 108 | 12 | CID000001959 |
| Drug | NSC60597 | 4.75e-06 | 140 | 108 | 7 | CID000003327 | |
| Drug | 0-to | 4.98e-06 | 141 | 108 | 7 | CID000002051 | |
| Drug | cnicin | 5.07e-06 | 92 | 108 | 6 | CID000091176 | |
| Drug | 4-chloroaniline | 5.51e-06 | 202 | 108 | 8 | CID000007812 | |
| Drug | NSC350593 | 5.54e-06 | 269 | 108 | 9 | CID000004364 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 4.70e-17 | 8 | 105 | 7 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 4.70e-17 | 8 | 105 | 7 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 4.70e-17 | 8 | 105 | 7 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 4.70e-17 | 8 | 105 | 7 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 7.01e-16 | 10 | 105 | 7 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.01e-16 | 10 | 105 | 7 | DOID:13832 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 1.25e-05 | 2 | 105 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.25e-05 | 2 | 105 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.25e-05 | 2 | 105 | 2 | C1853623 | |
| Disease | Brown-Vialetto-Van Laere syndrome (implicated_via_orthology) | 3.75e-05 | 3 | 105 | 2 | DOID:0050694 (implicated_via_orthology) | |
| Disease | brain glioblastoma multiforme (is_marker_for) | 7.49e-05 | 4 | 105 | 2 | DOID:3073 (is_marker_for) | |
| Disease | Uveoretinal Coloboma | 2.60e-04 | 7 | 105 | 2 | C4554007 | |
| Disease | descending aortic diameter | 2.81e-04 | 88 | 105 | 4 | EFO_0021788 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 3.46e-04 | 8 | 105 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 4.03e-04 | 268 | 105 | 6 | C0001973 | |
| Disease | N-acetylleucine measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0800116 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0800562 | |
| Disease | Congenital ocular coloboma (disorder) | 4.44e-04 | 9 | 105 | 2 | C0009363 | |
| Disease | taste liking measurement | 4.86e-04 | 388 | 105 | 7 | EFO_0010155 | |
| Disease | Familial dilated cardiomyopathy | 5.22e-04 | 44 | 105 | 3 | C0340427 | |
| Disease | Congenital neurologic anomalies | 5.54e-04 | 10 | 105 | 2 | C0497552 | |
| Disease | octadecanedioate measurement | 5.54e-04 | 10 | 105 | 2 | EFO_0021056 | |
| Disease | Cranioschisis | 5.54e-04 | 10 | 105 | 2 | C0265541 | |
| Disease | Gastrointestinal Stromal Sarcoma | 6.34e-04 | 47 | 105 | 3 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 7.60e-04 | 50 | 105 | 3 | C0238198 | |
| Disease | serum alanine aminotransferase measurement | GALK1 ACTG1 CYP4F2 SERINC2 ALDH1L1 DCAF5 ITK TENM4 ADAMTS9 RBFOX2 | 1.08e-03 | 869 | 105 | 10 | EFO_0004735 |
| Disease | triacylglycerol 48:4 measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0010407 | |
| Disease | Hypertrophic Cardiomyopathy | 1.11e-03 | 57 | 105 | 3 | C0007194 | |
| Disease | diet measurement | MGAM DSCAM NCAM1 HPSE2 MLLT10 CHRNA3 TENM4 HECW2 BTN2A3P PKHD1 CAMTA1 | 1.29e-03 | 1049 | 105 | 11 | EFO_0008111 |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 1.42e-03 | 62 | 105 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | infant expressive language ability | 1.46e-03 | 16 | 105 | 2 | EFO_0006316 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.57e-03 | 914 | 105 | 10 | EFO_0004532 | |
| Disease | calcium measurement | 1.84e-03 | 628 | 105 | 8 | EFO_0004838 | |
| Disease | Meningioma | 2.06e-03 | 19 | 105 | 2 | C0025286 | |
| Disease | R-warfarin measurement | 2.62e-03 | 265 | 105 | 5 | EFO_0803324 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGWQLGPPVKQELVS | 136 | A0A1B0GUX0 | |
| LECISGGWYPKPLTV | 161 | Q96KV6 | |
| RGYVKAGPWTPEAAV | 36 | Q93088 | |
| YETQGGKIPIRWTAP | 781 | P21709 | |
| SYPEGGVKVLITGPW | 881 | Q9Y6Y1 | |
| LKYTGEVTWIPPAIF | 141 | P32297 | |
| TPGKTPVDGQYVWFN | 201 | Q9Y4W6 | |
| IIAPPERKYSVWIGG | 331 | P68133 | |
| IAPPERKYSVWIGGS | 331 | Q562R1 | |
| GWGYIEEKAPRPSSI | 181 | P10323 | |
| YIPPLIWGKSGHIQT | 66 | P08910 | |
| APPERKYSVWIGGSI | 331 | P60709 | |
| APPERKYSVWIGGSI | 331 | P63261 | |
| IIAPPERKYSVWIGG | 331 | P62736 | |
| IAPPERKYSVWIGGS | 331 | P63267 | |
| IINYVSKVGSRPWVP | 256 | A6NFU0 | |
| KQWLYPLGVSTELIG | 26 | A0A0D9SF12 | |
| LVWGASKLVPVGYGI | 226 | P29692 | |
| PEAYWEVKPLSGNQG | 486 | Q149M9 | |
| VNVWPVKILGEYTSP | 896 | Q6ZP01 | |
| SWKPQPGDVIGYVVD | 546 | Q99650 | |
| VTPYANGWKLSPVVG | 206 | O43251 | |
| PYTNGWKLNPVVGAV | 186 | A6NFN3 | |
| NKWEVPSVYSGVILG | 546 | Q75QN2 | |
| KITYVANVNPGGWAP | 576 | Q9Y5P4 | |
| PQVPYTVSWVKLLEG | 41 | Q01151 | |
| TQKGQIVWRIEPGPY | 116 | Q9P2P5 | |
| VPPVYGLEVSDVSKW | 341 | Q9H3H1 | |
| PYKPVVLLNAQEGWS | 66 | Q6NYC1 | |
| GILVLEPQPWSSYGK | 611 | Q7L2J0 | |
| EWYVVPPGTKCEIAG | 596 | Q2TV78 | |
| IYKLPEGSPTWLGIS | 96 | Q13506 | |
| ALPEPTVTWYKDGQP | 3066 | Q8NDA2 | |
| GTNPLKLGYIEIWGV | 2686 | O43451 | |
| VGYGDVTPKIWPSQL | 296 | Q5JUK3 | |
| APPGTIVGYVTQKWD | 156 | A0PG75 | |
| PWTLKYSQPCIVKGG | 411 | A0A1B0GTH6 | |
| PGTPRWANYVKGVIQ | 101 | P51570 | |
| IIKIWSPYKQPGCTG | 356 | Q96JK2 | |
| KVPHPGSVGNLYSWQ | 1616 | Q9HD67 | |
| RGAYKVQVEGSPWVP | 561 | A0A1B0GTW7 | |
| YIPWKGQTSPGNCVL | 1476 | O60449 | |
| PWMGLLGPTIQAEVY | 86 | P00451 | |
| IINVGGIKYSLPWTT | 66 | Q9UIX4 | |
| YTPGKKIWLEGVVTT | 371 | Q8WWQ2 | |
| ITYEWAPPGVTQKLG | 116 | Q9NZU5 | |
| WTPPEGLQGVKVTYT | 56 | Q9UHF4 | |
| VPWAAEPGYLVTKVV | 576 | Q9Y5F1 | |
| DGVLLVWKPVESYGP | 7571 | Q5VST9 | |
| FQTYWVLGVPKAVLP | 261 | Q96BZ4 | |
| VAWPGATQPEAYVKG | 641 | Q9NQ11 | |
| GLLPNVRWVPKYSGI | 666 | Q9P2N4 | |
| YPGILTVTWKADGTP | 141 | P15814 | |
| KRSGITGWYPIILPE | 1331 | Q4AC94 | |
| KGYIWTHVGPTPAIT | 246 | Q8WUU5 | |
| NIWPGFSKLPLVGQY | 261 | Q15131 | |
| LVYQITWTPLGEGKA | 676 | Q9P218 | |
| QIPIKWTAPEALNYG | 721 | P16591 | |
| WQGGPQEPPKTTVYV | 51 | Q9H1C7 | |
| VTTYPQGFKLWLGPT | 81 | Q9HBI6 | |
| QQVWTLPYKIGVVGP | 46 | P51841 | |
| LPYKIGVVGPWACDS | 51 | P51841 | |
| SGVPAPQVYWLKDGQ | 246 | Q4KMG0 | |
| VATYPQGFKVWMGPI | 81 | P78329 | |
| HSWQPGIKNPYRGVV | 56 | Q8NDI1 | |
| GIKNPYRGVVVWPVP | 61 | Q8NDI1 | |
| WPSAGKVIPVGYRVA | 261 | Q8N7U6 | |
| YPVVDVKGLWTGTPF | 586 | Q68CP4 | |
| YLPGPWLSSGINQVI | 596 | Q8IW92 | |
| TCVKGPEVSGIWPKY | 501 | Q6ZMW3 | |
| SKVATPIWLLLYGGV | 556 | Q8WUM9 | |
| VWNGTVPEGSKPGTY | 271 | P19022 | |
| VGGILYQSAWIIAPK | 211 | Q12908 | |
| IYKTPKVGQWVGTVL | 156 | Q9H0X9 | |
| TTVLGELGWKTYPLN | 41 | Q9UF33 | |
| PVTAGLRYGKWVIDP | 346 | Q08881 | |
| YPVPTIVWKFSKGAG | 716 | O60469 | |
| APKYGGWIVDNCPIV | 626 | Q5TCS8 | |
| SVIKSPPGWEVGVYA | 11 | Q8IV01 | |
| KPWGITALPSGQFVV | 471 | Q13049 | |
| VPVGEKTTYRGWLGL | 681 | P08582 | |
| KISAGIEYPGEIRWP | 381 | Q9Y345 | |
| QPEIYWITPSGQKLL | 451 | Q9H3W5 | |
| PWLQTYVETVAIGGK | 31 | Q15573 | |
| GSPPETSLPYKWVVE | 281 | P10244 | |
| VVVKELPEGWSLPSY | 36 | Q9HAB3 | |
| GLWCGDPKTPDVYTQ | 236 | Q6UWY2 | |
| GPKVDIWSLGVVLYV | 241 | Q9Y2K2 | |
| SGVPGKLIHVYGWII | 146 | P08F94 | |
| TYTIVGITLWGGEIP | 266 | P29371 | |
| NKEIYTIKWSPTGPG | 391 | Q9BZK7 | |
| LIQVGKWNPVPLSYV | 131 | Q01826 | |
| IIAPPERKYSVWIGG | 331 | P68032 | |
| YGIVQVPTGPWFCRK | 56 | P55197 | |
| KEPVGVCGIIIPWNY | 561 | O75891 | |
| PGYVVTVLTWPGTNP | 56 | Q03154 | |
| PKLQGPVAVYTWEGN | 416 | P13591 | |
| PQGTPYEGGVWKVRV | 41 | P62256 | |
| VVVKDLPEGWSLPSY | 36 | Q9NWF4 | |
| QGGTRKLWEIPPYET | 261 | Q92545 | |
| KEYWVVARAGPVPSG | 366 | A8MQ27 | |
| PLQVTAIVKYWLGGP | 51 | Q9UMX1 | |
| KLNGTITSPGWPKEY | 626 | Q9Y6L7 | |
| TGMPLWLVVPDGQVY | 1636 | Q6N022 | |
| TPLVTWGAGIKYPQR | 281 | O95427 | |
| GLEDWPTLPIYQTTG | 2271 | Q8IUG5 | |
| CTPEPGEKWYQVGII | 256 | Q6UWB4 | |
| WYPIVVFLNPDSKQG | 721 | Q07157 | |
| LGVTPPGYSAWIKEE | 591 | Q9H1V8 | |
| NWIGEAPYKVGVPCS | 216 | O43692 | |
| VTKPPYEITETGWGE | 81 | O95619 | |
| YKLPWVCEEGAGIPT | 66 | Q96SA4 | |
| VDPTYLWIGPNEKTL | 66 | Q6X784 |